NO991827L - FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon - Google Patents

FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon

Info

Publication number
NO991827L
NO991827L NO991827A NO991827A NO991827L NO 991827 L NO991827 L NO 991827L NO 991827 A NO991827 A NO 991827A NO 991827 A NO991827 A NO 991827A NO 991827 L NO991827 L NO 991827L
Authority
NO
Norway
Prior art keywords
streptococcus pneumoniae
procedure
treatment
methods
pneumoniae infection
Prior art date
Application number
NO991827A
Other languages
English (en)
Other versions
NO991827D0 (no
Inventor
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of NO991827D0 publication Critical patent/NO991827D0/no
Publication of NO991827L publication Critical patent/NO991827L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse vedrorer fremgangsmåter for å drepe antibiotika-resistente patogene bakterier som forårsaker sykdommer hos mennesker og dyr. Spesielt fremgangsmåter til direkte å drepe antibiolika-resistente eller multi-medikament resistente Streptococcus pneumoniae bakteriestammer. Fremgangsmåtene anvender en lantocin slik som nisin eller en variant herav som baktericid.
NO991827A 1996-10-18 1999-04-16 FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon NO991827L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2881296P 1996-10-18 1996-10-18
PCT/US1997/018904 WO1998017303A1 (en) 1996-10-18 1997-10-14 A method for the treatment of streptococcus pneumoniae infection

Publications (2)

Publication Number Publication Date
NO991827D0 NO991827D0 (no) 1999-04-16
NO991827L true NO991827L (no) 1999-04-16

Family

ID=21845562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991827A NO991827L (no) 1996-10-18 1999-04-16 FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon

Country Status (13)

Country Link
US (1) US5910479A (no)
JP (1) JP2001506976A (no)
KR (1) KR20000049199A (no)
CN (1) CN1233186A (no)
AU (1) AU4909497A (no)
BR (1) BR9712633A (no)
CA (1) CA2264794A1 (no)
HU (1) HUP0000146A2 (no)
IL (1) IL128849A0 (no)
NO (1) NO991827L (no)
PL (1) PL332690A1 (no)
WO (1) WO1998017303A1 (no)
ZA (1) ZA979110B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
BR0316776A (pt) * 2002-12-10 2005-10-25 Biosynexus Inc Formula para anti-infeccioso tópico
WO2009141264A2 (en) * 2008-05-20 2009-11-26 Boehringer Ingelheim Vetmedica Gmbh Gallidermin to treat infections of the respiratory tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4548924A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
IN167138B (no) * 1988-08-17 1990-09-01 Hoechst India
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
US5866539A (en) * 1995-06-23 1999-02-02 Ambi Inc. Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Also Published As

Publication number Publication date
CA2264794A1 (en) 1998-04-30
ZA979110B (en) 1998-05-11
KR20000049199A (ko) 2000-07-25
CN1233186A (zh) 1999-10-27
IL128849A0 (en) 2000-01-31
US5910479A (en) 1999-06-08
WO1998017303A1 (en) 1998-04-30
NO991827D0 (no) 1999-04-16
PL332690A1 (en) 1999-09-27
JP2001506976A (ja) 2001-05-29
BR9712633A (pt) 1999-12-21
AU4909497A (en) 1998-05-15
HUP0000146A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
NO976028L (no) Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon
ATE290391T1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
CY1108646T1 (el) Προβιοτικο βακτηριο γαλακτικου οξεος για την αντιμετωπιση βακτηριακων λοιμωξεων συνδεομενων με sids
DE59508891D1 (de) Hautpflegemittel
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
BR9712962A (pt) Uma nova linhagem de bacilo para controle de doença de planta.
DE69636791D1 (de) Derivate von glykopeptidantibiotika
DE69713408D1 (de) Streptococcus equi Impstoff
NO985644L (no) Antimikrobielle midler som orale hygieneprodukter
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
BR9713812A (pt) Controle biológico de infecções fúngicas de planta
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
BR0006291A (pt) Bactéria do gênero salmonella, vacina para aproteção de animais contra a salmonelose, uso deuma bactéria, e, processo para a preparação deuma vacina
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
NO20023630L (no) Anvendelse av retinoid-type forbindelser som antibakterielle midler
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
DE60008562D1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére
ATE460920T1 (de) Verwendung von synergistischen lytischen enzymen aus bakteriophagen zur vorbeugung und behandlung bakterieller infektionen
RU96104662A (ru) Штамм бактерий bacillus subtilis, используемый для обеззараживания птичьего помета и навоза от патогенных микроорганизмов
SE8802084D0 (sv) Farmaceutiskt preparat och konjugat av en baktericid och en antikropp

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application